BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biotech

Merck’s First-Asia Pacific Mobius® Single-Use Manufacturing Center in Wuxi, China

Investment Supports Biotech Innovation in China Partnership with Administrative Management Committee of Wuxi National High-Tech Industrial Development Z...

May 06, 2022 | News

Biocytogen Enters into Antibody Agreement with Merck

Under the agreement, Biocytogen will provide Merck antibodies directed against at least three targets specified by them from Biocytogen's Project Integrum&...

May 02, 2022 | News

Seegene unveils world's first commercialized '3 Ct' PCR assay

"Dream MDx technology" developed based on Seegene's 20-year expertise; combines 19 different patented technologies, including DPO™, TOCE™, Mu...

April 27, 2022 | News

Thermo Fisher opens bioprocessing manufacturing facility in Ogden, UT

Thermo Fisher Scientific today celebrated the opening of its new single-use technology manufacturing site in Ogden, Utah. The state-of-the-art facility cre...

April 21, 2022 | News

MGI announces partnership with Nalagenetics to advance personalized medicine

MGI, a company committed to being a world-leading life science innovator, today announced a partnership with Nalagenetics (NALA) to co-develop lo...

April 19, 2022 | News

CDD Vault Integrates with SnapGene Server for Web-Based Sharing of Plasmid Information

This integration allows users to visualize and share plasmid information such as maps and sequences within the web-based CDD Vault application. Snap...

April 18, 2022 | News

Agilent Joins AMBIC to Advance Biomanufacturing

Agilent Technologies Inc. (NYSE: A) announced today that it has become a member of the Advanced Mammalian Biomanufacturing Innovation Center (AMB...

April 14, 2022 | News

HanAll Biopharma and Daewoong Pharmaceutical Invest in Turn Biotechnologies to Expand Growth Initiative

HanAll Biopharma (KRX: 009420.KS) and Daewoong Pharmaceutical (KRX: 069620.KS) today announced expansion of their open collaboration strategy by investing ...

April 13, 2022 | News

Global pharma organizations back Turn Biotechnologies to advance its cell rejuvenation program

Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced that it clos...

April 12, 2022 | News

Pregene Enters into Innovative Partnership with CellPoint to Develop anti-BCMA CAR-T Cell Therapy in Europe and the US

PRG-1801 is a single domain antibody anti-BCMA CAR-T cell therapy in development for the treatment of relapsed/refractory multiple myeloma that has demonst...

April 07, 2022 | News

Microba Life Sciences and Ginkgo Bioworks Announce Partnership to Discover Novel Live Biotherapeutics

Microba Life Sciences (ASX:MAP), a precision microbiome science company, and Ginkgo Bioworks (NYSE: DNA), the leading horizontal ...

April 05, 2022 | News

CanSinoBIO's COVID-19 mRNA Vaccine Receives Approval of Clinical Trial Application in China

Pre-clinical trial results showed that CanSinoBIO's COVID-19 mRNA vaccine can induce high-titer neutralizing antibody levels against multiple SARS-CoV-2 va...

April 04, 2022 | News

Fujifilm to Acquire Shenandoah Biotechnology

Acquisition offers customers worldwide a single point of access for cGMP cell culture solutions for biopharmaceuticals, and cell and gene therapies FUJIFI...

March 24, 2022 | News

Novavax and SII Announce First EUA of Novavax' COVID-19 Vaccine in Adolescents ≥12 to <18 in India

Covovax™ (SARS-CoV-2 rS Protein (COVID-19) recombinant spike protein Nanoparticle Vaccine) is the first protein-based COVID-19 vaccine authorized&n...

March 23, 2022 | News

Stay Connected